Edit Reading

Back to List

Basic Information

Title

Please enter a title.

URL

Please enter a valid URL.

Date

カテゴリID

画像ファイル名

統計情報

単語数: 215語

読了回数: 0回

作成日: 2022/08/16 06:32

更新日: 2025/12/09 14:19

本文

Britain&#039;s medicine regulator has approved a coronavirus vaccine made by Moderna that targets both the original strain and the Omicron variant.
                
The regulator announced on Monday that it gave the green light to the so-called bivalent vaccine from the US drug maker as a booster for adults aged 18 and older.
                
Officials said a clinical trial showed that the bivalent booster shot triggers a strong immune response against both the BA.1 Omicron subvariant and the original strain.
                
The bivalent vaccine was also found to generate a good immune response against BA.4 and BA.5 -- two subvariants that are dominant among Omicron infections.
                
Local media reported that the UK became the first country to approve the Omicron-tailored vaccine.
                
The chief executive of the Medicines and Healthcare products Regulatory Agency said the vaccine gives Britons &quot;a sharpened tool in our armory to help protect us against this disease as the virus continues to evolve.&quot;
                
Moderna said in a statement that the bivalent vaccine &quot;has an important role to play in protecting people in the UK from COVID-19 as we enter the winter months.&quot;
                
The company said it has completed regulatory submissions for the bivalent shot in Australia, Canada and the European Union. It also applied to Japan&#039;s health ministry last week to gain approval for the vaccine.

本文を入力してください。

メモ

メモ・感想

キャンセル

Edit Reading

Basic Information

統計情報

本文

メモ

Send Report